Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer Cells
暂无分享,去创建一个
Jonathan M Irish | Garry P Nolan | Peter O. Krutzik | Øystein Bruserud | O. Perez | G. Nolan | Ø. Bruserud | J. Irish | B. Gjertsen | R. Hovland | Peter O Krutzik | Omar D Perez | Bjørn T Gjertsen | Randi Hovland | P. Krutzik
[1] L. Platanias. Map kinase signaling pathways and hematologic malignancies. , 2003, Blood.
[2] K. Shuai,et al. Regulation of JAK–STAT signalling in the immune system , 2003, Nature Reviews Immunology.
[3] Claire Tilstone. DNA microarrays: Vital statistics , 2003, Nature.
[4] B. Gjertsen,et al. In vitro culture of human acute myelogenous leukemia (AML) cells in serum-free media: studies of native AML blasts and AML cell lines. , 2000, Journal of hematotherapy & stem cell research.
[5] T. Naoe,et al. Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain , 2002, Oncogene.
[6] Nicola Gebbia,et al. STAT proteins: From normal control of cellular events to tumorigenesis , 2003, Journal of cellular physiology.
[7] Jonathan M Irish,et al. Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. , 2004, Clinical immunology.
[8] N. Russell,et al. Flow cytometric measurement of phosphorylated STAT5 in AML: lack of specific association with FLT3 internal tandem duplications. , 2003, Leukemia research.
[9] W. Berdel,et al. Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. , 2000, Blood.
[10] J. Downing,et al. Acute myeloid leukemia. , 1999, The New England journal of medicine.
[11] R. Gray,et al. A simple, robust, validated and highly predictive index for the determination of risk‐directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial , 1999, British journal of haematology.
[12] Matthew B. Wilson,et al. Control of myeloid differentiation and survival by Stats , 2000, Oncogene.
[13] J. McCubrey,et al. Serine/threonine phosphorylation in cytokine signal transduction , 2000, Leukemia.
[14] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[15] Chunaram Choudhary,et al. Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations. , 2003, Blood.
[16] Z. Xia,et al. Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts. , 1998, Cancer research.
[17] R. Jove,et al. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[18] J. Griffin,et al. The roles of FLT3 in hematopoiesis and leukemia. , 2002, Blood.
[19] Zang Ai-hua,et al. Stem Cells,Cancer and Cancer Stem Cells , 2005 .
[20] P. Coffer,et al. The role of STATs in myeloid differentiation and leukemia , 2000, Oncogene.
[21] B. Calabretta,et al. Signal Transducer and Activator of Transcription (STAT)5 Activation by BCR/ABL Is Dependent on Intact Src Homology (SH)3 and SH2 Domains of BCR/ABL and Is Required for Leukemogenesis , 1999, The Journal of Experimental Medicine.
[22] W. Berdel,et al. Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. , 2000, Blood.
[23] Garry P. Nolan,et al. Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry , 2002, Nature Biotechnology.
[24] J. Turkson,et al. STAT proteins: novel molecular targets for cancer drug discovery , 2000, Oncogene.
[25] Roy Garcia,et al. STATs in oncogenesis , 2000, Oncogene.
[26] W. Berdel,et al. Flt 3 mutations from patients with acute myeloid leukemia induce transformation of 32 D cells mediated by the Ras and STAT 5 pathways , 2000 .
[27] G. Ehninger,et al. Analysis of Flt3-activating Mutations in 979 Patients with Acute Myelogenous Leukemia: Association with Fab Subtypes and Identification of Subgroups with Poor Prognosis , 2022 .
[28] Peter O. Krutzik,et al. Intracellular phospho‐protein staining techniques for flow cytometry: Monitoring single cell signaling events , 2003, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[29] E. Vellenga,et al. Regulation of constitutive STAT5 phosphorylation in acute myeloid leukemia blasts , 2000, Leukemia.
[30] Z. Xia,et al. Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival. , 2002, Blood.
[31] Heinz Baumann,et al. Signal transducer and activator of transcription proteins in leukemias. , 2003, Blood.
[32] S. Menon,et al. Administration of Flk2/Flt3 ligand induces expansion of human high-proliferative potential colony-forming cells in the SCID-hu mouse. , 1999, Experimental hematology.
[33] T. Naoe,et al. Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines , 2000, Oncogene.
[34] J. Radich,et al. The role of FLT3 in haematopoietic malignancies , 2003, Nature Reviews Cancer.
[35] S. Rane,et al. JAKs, STATs and Src kinases in hematopoiesis , 2002, Oncogene.
[36] Ø. Bruserud,et al. Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of Flt3-ligand effects in AML cell populations with and without genetic Flt3 abnormalities. , 2003, Haematologica.
[37] W. Hiddemann,et al. Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells. , 2002, Experimental hematology.